Sucessful lung transplantation for talcosis secondary to intravenous abuse of oral drug

International Journal of COPD

Volumn 3, Issue 2, 2008, Pages 327-330

  Shlomi, Dekel ^a,b   Shitrit, David ^a,b   Bendayan, Daniele ^a,b   Sahar, Gidon ^a,b   Shechtman, Yitshak ^a,b   Kramer, Mordechai R ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Emphysema; Methylphenidale(Ritalin)

Indexed keywords

ANTIBIOTIC AGENT; IPRATROPIUM BROMIDE; METHYLPHENIDATE; PREDNISONE; SALBUTAMOL; CENTRAL STIMULANT AGENT; TALC;

ADULT; ARTERIAL GAS; ARTICLE; BACTERIAL PNEUMONIA; BIREFRINGENCE; CARBON DIOXIDE TENSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; GIANT CELL; GRAFT RECIPIENT; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ABUSE; LUNG ARTERY PRESSURE; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG FIBROSIS; LUNG PERFUSION; LUNG TRANSPLANTATION; LUNG WEDGE PRESSURE; OXYGEN SATURATION; OXYGEN TENSION; POSTOPERATIVE PERIOD; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; RESIDUAL VOLUME; RHEUMATOID ARTHRITIS; SMOKING; SYMPTOM; TALC PNEUMOCONIOSIS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; SUBSTANCE ABUSE; TABLET;

CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAVENOUS; LUNG DISEASES; LUNG TRANSPLANTATION; METHYLPHENIDATE; MIDDLE AGED; SUBSTANCE ABUSE, INTRAVENOUS; TABLETS; TALC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47849105931     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cook RC, Fradet G, English JC, et al. 1998. Recurrence of intravenous talc granulomatosis following single lung transplantation. Can Respir J, 5:511-14.
2. Crouch E, Churg A. 1983. Progressive massive fibrosis of the lung secondary to intravenous injection of talc. A pathologic and mineralogic analysis. Am J Clin Pathol, 80:520-6.
3. DiMartini A, Weinrieb R, Fireman M. 2002. Liver transplantation in patients with alcohol and other substance use disorders. Psychiatr Clin North Am, 25:195-209.
4. Feigin DS. 1986. Talc: understanding its manifestations in the chest. Am J Roentgenol, 146:295-301.
5. Fields TA, McCall SJ, Reams BD, et. al. 2005. Pulmonary embolization of microcrystalline cellulose in a lung transplant recipient. J Heart Lung Transplant, 24:624-7.
6. Gibbs AE, Pooley FD, Griffiths DM, et al. 1992. Talc pneumoconiosis: a pathologic and mineralogic study. Hum Pathol, 23:1344-54.
7. Katzenstein A-LA. 1997. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Diseases, vol 13, 3rd ed. Philadelphia, PA: W.B. Saunders Company, pp. 130-1.
8. Lockey JE. 1981. Nonasbestos fibrous minerals. Clin Chest Med, 2:203-18.
9. Paré JA, Cote G, Fraser RS. 1989. Long-term follow-up of drug abusers with intravenous talcosis. Am Rev Respir Dis, 139:233-41.
10. Paré JA, Fraser RG, Hogg JC, et al. 1979. Pulmonary 'mainline' granulomatosis: talcosis of intravenous methadone abuse. Medicine (Baltimore), 58:229-39,
11. Sieniewicz DJ, Nidecker AC. 1980. Conglomerate pulmonary disease: a form of talcosis in intravenous methadone abusers. Am J Roentgenol, 135:697-702.
12. Stern EJ, Frank MS, Schmutz JF, et al. 1994. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. Am J Roentgenol, 162:555-60.
13. Ward S, Heyneman LE, Reittner P, et al. 2000. Talcosis associated with IV abuse of oral medications: CT findings. Am J Roentgenol, 174:789-93.